What is Rosacea? (VIDEO) interviews Dr. Robert A. Weiss at the 2013 ASDS Annual Meeting in Chicago. Weiss discusses the cause, potential aggravators, and available treatments for rosacea.
Botulinum toxin a possible therapeutic option for rosaceaIntradermal neuromodulator injections show promise for treating rosacea — particularly in the form of erythematotelangiectatic rosacea, flushing and rhinophyma, experts say.
Ivermectin effective for rosaceaTopical ivermectin cream 1 percent has shown safety and statistically superior efficacy versus vehicle as early as week two of treatment in phase 3 trials.
Clues about rosacea pathogenesis spark treatment advances
Clues about rosacea pathogenesis spark treatment advancesAs researchers learn more about the pathogenesis of rosacea, they can better understand the benefits of certain medications and find opportunities for new therapies.
Topical ivermectin emerges as option for rosacea
Topical ivermectin emerges as option for rosaceaIn the search for rosacea treatments, topical ivermectin 1 percent cream met its safety endpoints in two pivotal trials that included a total of 910 actively treated subjects, Galderma announced at the 72nd Annual Meeting of the American Academy of Dermatology.
Mirvaso shows long-term efficacy for facial rednessResults of a long-term, multicenter study show that brimonidine is effective in treating moderate-to-severe facial erythema caused by rosacea.
More highlights from MauiDerm 2014New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.
Future of dermatologic innovation has bright spotsWhile government funds for research in dermatology and other medical specialties seems to be dwindling, there are forces at work that could help to pick up at least part of the slack.
Study finds evidence for rosacea subtype progression
Study finds evidence for rosacea subtype progressionA study shows data to suggest there is evidence of subtype progression in rosacea, and that flushing is not a universal characteristic of patients with subtype 1 rosacea.
Research sheds light on pathophysiology of acne, rosacea
Research sheds light on pathophysiology of acne, rosaceaAlthough the symptoms of acne and rosacea are well established, clear and definitive etiologies of these conditions have largely been unknown. Recent research, however, has shed new light into the pathophysiology of these conditions, paving the way for more targeted therapies.